1. Home
  2. VANI vs DRIO Comparison

VANI vs DRIO Comparison

Compare VANI & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VANI
  • DRIO
  • Stock Information
  • Founded
  • VANI 1998
  • DRIO 2011
  • Country
  • VANI United States
  • DRIO United States
  • Employees
  • VANI N/A
  • DRIO N/A
  • Industry
  • VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • DRIO Medical/Dental Instruments
  • Sector
  • VANI Health Care
  • DRIO Health Care
  • Exchange
  • VANI Nasdaq
  • DRIO Nasdaq
  • Market Cap
  • VANI 81.2M
  • DRIO 87.0M
  • IPO Year
  • VANI 2014
  • DRIO N/A
  • Fundamental
  • Price
  • VANI $1.47
  • DRIO $13.15
  • Analyst Decision
  • VANI Strong Buy
  • DRIO Strong Buy
  • Analyst Count
  • VANI 1
  • DRIO 2
  • Target Price
  • VANI $4.00
  • DRIO $50.00
  • AVG Volume (30 Days)
  • VANI 154.3K
  • DRIO 146.4K
  • Earning Date
  • VANI 11-12-2025
  • DRIO 11-06-2025
  • Dividend Yield
  • VANI N/A
  • DRIO N/A
  • EPS Growth
  • VANI N/A
  • DRIO N/A
  • EPS
  • VANI N/A
  • DRIO N/A
  • Revenue
  • VANI N/A
  • DRIO $27,148,000.00
  • Revenue This Year
  • VANI N/A
  • DRIO N/A
  • Revenue Next Year
  • VANI N/A
  • DRIO $59.84
  • P/E Ratio
  • VANI N/A
  • DRIO N/A
  • Revenue Growth
  • VANI N/A
  • DRIO 41.79
  • 52 Week Low
  • VANI $0.91
  • DRIO $5.94
  • 52 Week High
  • VANI $1.80
  • DRIO $31.00
  • Technical
  • Relative Strength Index (RSI)
  • VANI 56.91
  • DRIO 53.80
  • Support Level
  • VANI $1.36
  • DRIO $14.62
  • Resistance Level
  • VANI $1.45
  • DRIO $15.98
  • Average True Range (ATR)
  • VANI 0.07
  • DRIO 1.39
  • MACD
  • VANI -0.01
  • DRIO -0.61
  • Stochastic Oscillator
  • VANI 68.00
  • DRIO 2.44

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.

About DRIO DarioHealth Corp.

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

Share on Social Networks: